ENGINEERED RESIDUE IN CHAIN A, CYS 23 TO ALA ENGINEERED RESIDUE IN CHAIN B, CYS 23 TO ALA ...ENGINEERED RESIDUE IN CHAIN A, CYS 23 TO ALA ENGINEERED RESIDUE IN CHAIN B, CYS 23 TO ALA ENGINEERED RESIDUE IN CHAIN C, CYS 23 TO ALA
配列の詳細
N-TERMINAL HIS-TAG CONSTRUCT WITH ENTEROKINASE CLEAVAGE SITE.
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 2.5 Å3/Da / 溶媒含有率: 50.5 % / 解説: NONE
結晶化
詳細: 16-18% PEG 4000, 100 MM HEPES PH 7.0, 10 MM ZNCL2.
解像度: 2.26→47.18 Å / Cor.coef. Fo:Fc: 0.94 / Cor.coef. Fo:Fc free: 0.911 / 交差検証法: THROUGHOUT / ESU R: 0.284 / ESU R Free: 0.214 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD / 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
Rfactor
反射数
%反射
Selection details
Rfree
0.23274
1996
5 %
RANDOM
Rwork
0.18472
-
-
-
obs
0.18713
37917
100 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.4 Å / 溶媒モデル: MASK